Search by Journal
- HOME
- > Search by Journal
- > Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Volume 26, Issue / 2016


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
In the 26th Japan circulation Japanese Pharmacological Society holding 山田充彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 3-3, 2016. |
---|
![]() |
LOX-1 from a vascular endothelium receptor to a biophylaxis receptor: 沢村達也, 藤田佳子, 垣野明美 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 22-22, 2016. |
---|
![]() |
Abacterial inflammation and inflammasome in S-1 cardiovascular procedure disease 高橋将文 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 24-24, 2016. |
---|
![]() |
Organ protection effect after the cardiopulmonary resuscitation with the S-2 hydrogen gas 佐野元昭 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 26-26, 2016. |
---|
![]() |
Possibility of the new molecular target treatment for the S-3 Marfan's syndrome 赤澤宏 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 28-28, 2016. |
---|
![]() |
Pulmonary hypertension promotion mechanism with the S-4 new etiology protein seleno protein P 佐藤公雄, 菊地順裕, 下川宏明 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 30-30, 2016. |
---|
![]() |
Development of the intractable skin ulcer therapeutic drug using the S-5 new functional peptide 中神啓徳 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 32-32, 2016. |
---|
![]() |
Elucidation of the functional significance of new APJ ligand ELABELA in the YIA-01 heart failure condition of a patient 佐藤輝紀1),2), 山口智和1), 渡邊博之2), 門脇歩美1), 佐藤チトセ1), 伊藤宏2), 今井由美子3), 久場敬司1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 36-36, 2016. |
---|
![]() |
Elucidation of the mRNA poly(A) resolution of the YIA-02 heart and the interaction mechanism of the energy perception signal 山口智和1), 鈴木享1), 佐藤輝紀1), 夏井美幸1), 門脇歩美1), 佐藤チトセ1), 小泉幸央1), 高橋明格3), 山本雅3), 今井由美子2), 久場敬司1),4) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 37-37, 2016. |
---|
![]() |
YIA-03 Cardio-Oncology: Antitumor agents sunitinib brings about HFpEF prior to HFrEF 和田剛, 安東賢太郎, 千葉浩輝, 曹新, 中村裕二, 中瀬古 (泉) 寛子, 杉山篤 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 38-38, 2016. |
---|
![]() |
Adjustment of the myocardium cell death by YIA-04 Bcl-2 associated athanogene(BAG)3 猪俣結衣1), 後藤雄太1), 松下尚子2), 東尾里英子1), 弘瀬雅教2), 三部篤1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 39-39, 2016. |
---|
![]() |
Participation of the sigma 1 receptor in depression-like behavior of the YIA-05 pressure load cardiac hypertrophy model mouse 篠田康晴, 田頭秀章, 福永浩司 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 40-40, 2016. |
---|
![]() |
Participation of the type 3 ryanodine receptor for the calcium mobilization mechanism control in cells of the YIA-06 vascular smooth muscle 松木克仁1), 加藤大樹1), 竹本将士1), 鈴木良明1), 山村寿男1), 大矢進2), 竹島浩3), 今泉祐治1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 41-41, 2016. |
---|
![]() |
Functional role of Kir2.1 for the cell growth of the hypoxia stress load cerebral blood vessel endothelial cells which assumed YIA-07 cerebral ischemia 山村英斗1), 鈴木良明1), 山村寿男1), 浅井清文2), 今泉祐治1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 42-42, 2016. |
---|
![]() |
Possibility as the effect to a pulmonary vein myocardium some other place characteristics spontaneous activity of the YIA-08 late INa selective blocking agent and the new atrial fibrillation therapeutic drug 入江雅彦, 古市龍輝, 金子美佳, 大塚健太郎, 実方春香, 濱口正悟, 行方衣由紀, 田中光 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 43-43, 2016. |
---|
![]() |
The inhibition of the YIA-09 SDF-1α-CXCR4 signal improves diabetic retinopathy 大森啓介1), 倉田薫里2), 藤井信孝3), 植村明嘉2), 村田幸久1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 44-44, 2016. |
---|
![]() |
Analysis of the molecular mechanism that YIA-10 platelet-derived growth factor makes Cav1.2 L-form Ca2+ channel of the vascular smooth muscle activate 郭暁光, 柏原俊英, 中田勉, 山田充彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 45-45, 2016. |
---|
![]() |
Effect of acetaldehyde giving it to a shrinkage response of the A-01 frog myocardium and a membrane ion current 陳福士1), 百瀬弥寿徳2), 広瀬仁美3), 土田勝晴3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 46-46, 2016. |
---|
![]() |
Effect for the chronic pressure load-induced heart remodeling of A-02 sodium - glucose attendant transportation 1 (SGLT1) 石田菜々絵1), 松下尚子2), 三部篤3), 丹治麻希1), 衣斐美歩1), Koepsell Hermann4), 平英一5), 弘瀬雅教1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 47-47, 2016. |
---|
![]() |
The shape control of the L-form Ca2+ channel electric current in ventricular line action potential by the A-03β adrenergic receptor stimulation and the molecular mechanism 西村仁志1),2), 柏原俊英1), 中田勉1), Findlay Ian3), 倉智嘉久4), 山田充彦1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 48-48, 2016. |
---|
![]() |
hERG channel inhibitory action and the facilitation effect of the A-04 antiarrhythmic drug: Significance in molecular mechanism and arrhythmia treatment 古谷和春, 津元国親, 倉智嘉久 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 49-49, 2016. |
---|
![]() |
Depressant action of YM-244769 (new NCX inhibitor) for Na/Ca exchanger (NCX) of A-05 ventricular cardiac muscle cells 渡邊泰秀1), 山下寛奈1), 木村純子2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 50-50, 2016. |
---|
![]() |
Molecular biologic study of the new Cl- electric current in A-06 cardiac muscle cells 岡本洋介, 石井邦明 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 51-51, 2016. |
---|
![]() |
Possibility of the atrial fibrillation onset due to the A-07 adiposity type cardiomyopathy 下田咲子1), 松下尚子2), 鈴木仁弥3), 佐藤さつき3), 石田菜々絵1), 丹治麻希1), 衣斐美歩1), 平英一4), 弘瀬雅教1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 52-52, 2016. |
---|
![]() |
Atrial fibrillation after cardiovascular procedures in the A-08 our hospital 小松正樹, 御子柴透, 町田海, 市村創, 山本高照, 五味渕俊仁, 中原孝, 大橋伸朗, 大津義徳, 和田有子, 瀬戸達一朗, 福井大祐, 岡田健次 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 53-53, 2016. |
---|
![]() |
Evaluation of the proarrhythmic risk of A-09 non-fixed form antipsychotics paliperidone 千葉浩輝1),3), 和田剛2), 曹新1), 中村裕二2), 中瀬古 (泉) 寛子2), 安東賢太郎2), 杉山篤2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 54-54, 2016. |
---|
![]() |
Ca2+ isolation properties of the type 2 ryanodine receptor (RyR2) variant causing A-10 idiopathy ventricular fibrillation 呉林なごみ1), 村山尚1), 哲翁直之1), 太田亮作2), 山下冨義2), 小川治夫3), 鈴木純二4), 金丸和典4), 飯野正光4), 櫻井隆1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 55-55, 2016. |
---|
![]() |
Rating system of the anticancer agent cardiotoxicity by the movement vector analysis of cardiac muscle cells derived from A-11 humans iPS 黒川洵子1), 児玉昌美1), 高橋健太郎1), 諫田泰成2), 酒徳航平3), 山崎泰広3), 古川哲史1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 56-56, 2016. |
---|
![]() |
Calcium signal control abnormal mechanism in cells in the A-12 diabetes myocardium 赤羽悟美1), 杉本結衣1), 濱口正悟2), 三上義礼1), 伊藤雅方1), 行方衣由紀2), 田中光2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 57-57, 2016. |
---|
![]() |
Mitochondrial function control and myocardium stress defense mechanisms through the calcium sensor in A-13 cells 西谷 (中村) 友重1), 若林繁夫2), 中川修1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 58-58, 2016. |
---|
![]() |
Quality control of the myocardial mitochondria by the A-14 Drp1- cytoskeletal interaction 西村明幸1), 島内司1), 2), 石川達也3), 冨田拓郎1), 西田基宏1),2),4) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 59-59, 2016. |
---|
![]() |
The presence of the A-15 collateral pathway promotes the occurrence of crown steal phenomenon: Difference in electrocardiogram ST change after the dipyridamole load in a healthy dog and the pig 安東賢太郎1), 中村裕二1), 星合清隆1), 小原浩2), 曹新1), 和田剛1), 中瀬古 (泉) 寛子1), 高原章3), 杉山篤1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 60-60, 2016. |
---|
![]() |
The myocardium injury in the A-16 cecum ligation perforation-induced septicemic model mouse and catecholamine-responsive change 酒井麻里1),2), 鈴木登紀子1), 冨田賢吾1), 山下重幸1),2), 芳村直樹2), 服部裕一1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 61-61, 2016. |
---|
![]() |
Cerebral blood flow control by the ceruleus nucleus through the B-01 astrocyte 関谷敬1), 北島奈美1), 金丸和典1), 田中謙二2), 飯野正光1),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 62-62, 2016. |
---|
![]() |
A depression effect of flaxseed in the B-02 DOCA salt loading high blood pressure model rat and examination of the mechanism of action 渡部裕介, 大畑佳織, 深野木文香, 藤本直人, 松本万瑠里, Naseratun Nessa, 鳥羽裕恵, 小原幸, 中田徹男 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 63-63, 2016. |
---|
![]() |
The B-03 high absorbance curcumin inhibited inflammation associated with the arteriosclerosis in patients with COPD 船本雅文1),2), 砂川陽一1),2),3), 刀坂泰史1),2),3), 宮崎雄輔1),2), 今泉厚4), 掛谷秀昭5), 山陰一2), 浅原哲子2), 和田啓道2), 長谷川浩二2), 森本達也1),2),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 64-64, 2016. |
---|
![]() |
Protection of chemokines in the extension stimulation inductivity cell death of the B-04 rat vascular smooth muscle 趙晶, 小澤健太郎, 京谷陽司, 吉栖正典 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 65-65, 2016. |
---|
![]() |
Role of smooth muscle origin HIF-1α in the B-05 aortic aneurysm formation 今西正樹1),2), 松永慎司1),3), 石澤啓介2),4), 玉置俊晃5), 冨田修平1),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 66-66, 2016. |
---|
![]() |
The SGLT2 inhibitor administration after the B-06 renal ischemia reperfusion inhibits extension of chronic kidney fibrosis 西山成, Zang Yifan, 人見浩史, 中野大介 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 67-67, 2016. |
---|
![]() |
Acute renal tubules effect of the SGLT2 inhibitor in the B-07 anesthesia rat 西山成1), 藤澤良秀2), ラフマン アサダー1), 中野大介1), 人見浩史1), 北田研人1), アンサリー チュバ1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 68-68, 2016. |
---|
![]() |
Examination - of the significance - vascular endothelium-specific C type natriuresis peptide knockout mouse of the B-08 vessel walls natriuresis peptide system 中尾一泰1),2), 桑原宏一郎1), 錦見俊雄1), 中川靖章1), 木下秀之1), 徳留健2), 南野直人2), 木村剛1), 寒川賢治2), 中尾一和3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 69-69, 2016. |
---|
![]() |
Improvement effect by vascular endothelial cells disorder and the astaxanthin through the oxidative stress by the B-09 glucose change 鈴木登紀子, 今泉貴博, 冨田賢吾, Abdelzaher Lobna, 服部裕一 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 70-70, 2016. |
---|
![]() |
The B-10 denaturation LDL activates GPCR through LOX-1 and causes intracellular signal transduction 垣野明美1),2), 山本浩一3), 藤田佳子2), 楽木宏美3), 沢村達也2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 71-71, 2016. |
---|
![]() |
The effect that B-11 aging gives to a soluble guanylate cyclase redox state 田和正志1), 下里貴2), 岩崎広高1), 今村武史1), 岡村富夫1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 72-72, 2016. |
---|
![]() |
Expansion response through beta 1, the beta 2 in B-12 rat retinal blood vessels and the beta-3 adrenergic receptor stimulation 森麻美, 關戸茜衣, 三輪朋代, 牛久保裕子, 坂本謙司, 中原努 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 73-73, 2016. |
---|
![]() |
The B-13 standstill type stellate cell of liver shrinks by a neurotransmitter 岩見恭介, 若林夢人, 齊藤真也, 石川智久 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 74-74, 2016. |
---|
![]() |
B-14 nitroso nifedipine inhibits dermal flap necrosis in an ischemic dermal flap model 石澤有紀1), 福永豊1),2), 西良恵理子1), 今西正樹3), 堀ノ内裕也1), 池田康将1), 座間味義人3),4), 武智研志6), 石澤啓介3),4), 土屋浩一郎5), 橋本一郎2), 玉置俊晃1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 75-75, 2016. |
---|
![]() |
The role that the blood vessel remodeling through the B-15 TRPM7 channel serves as for the condition of a patient formation of the pulmonary hypertension 平石敬三1), 倉原琳1), 胡耀鵬1), 古賀佳織2), 鬼塚美樹2), 阿部弘太郎3), 佐藤徹4), Yuwen Jian5), 井上隆司1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 76-76, 2016. |
---|
![]() |
Role of the TRPC6 channel in B-16 peripheral circulatory disorder 冨田 (沼賀) 拓郎1), 島内司1),2), 西村明幸1), 西田基宏1),2),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 77-77, 2016. |
---|
![]() |
Usefulness of the angiotensin II AT1 receptor blockade olmesartan administration to a B-17 monochrome thalline pulmonary hypertension rat 山下諒輔1), 斉藤麻希1), 田辺由幸1), 鎌滝章央2), 澤井高志2), 神田健太郎1), 金子遥1), 中山貢一1), 衣斐美歩1), 弘瀬雅教1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 78-78, 2016. |
---|
![]() |
Expression of non-structural scoliosis ECM ingredient matricellular proteins change in the B-18 monochromatic thalline-induced rat enlargement right ventricle 井本圭亮, 岡田宗善, 山脇英之 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 79-79, 2016. |
---|
![]() |
Role of the renin-angiotensin system in GVHD pulmonary after B-19 bone marrow transplantation 今井由美子1), 藤原誠樹1), 原隆二郎1),3), 鬼塚真仁3), 久場敬司2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 80-80, 2016. |
---|
![]() |
NO synthase-based a variety of roles in the origin of B-20 respiratory illness 筒井正人1), 生越貴明2), 野口真吾2), 赤田憲太朗2), 柳原延章3), 下川宏明4), 迎寛5), 矢寺和博2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 81-81, 2016. |
---|
![]() |
Platelet aggregation promotion effect of B-21 prostaglandin F2α 柏木仁1), 結城幸一1), 今道力敬1), 小島史章2), 粂井志麻1), 成宮周3), 牛首文隆1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 82-82, 2016. |
---|
![]() |
Carbohydrate chain by the B-22 miR-30-GALNT1, 2 course-modified adjustment is involved in proBNP secretion from morbid myocardium 中川靖章1), 桑原宏一郎1), 錦見俊雄1),2), 木下秀之1), 稲住英明1), 森内健史1), 南野直人3), 中尾一和4), 木村剛1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 83-83, 2016. |
---|
![]() |
Development of the new transplantation of cardiac muscle cells derived from B-23 pluripotent stem cells 小笠原達樹1), 南一成2), 上杉志成2), 市村創1),3), 和田有子3), 市原由香4), 田中夕祈3), 唐津優子1), 岡野怜己1), 岡田健次3), 柴祐司1),4) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 84-84, 2016. |
---|
![]() |
Identification of the bond membrane localization motif of the B-24 myocardium L-form Ca2+ channel 中田勉, 柏原俊英, 山田充彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 85-85, 2016. |
---|
![]() |
Discovery and functional analysis of new associated gene GSTK1 of the B-25 hypertrophic cardiomyopathy 西村有平1),2),3),4),5), 笹川翔太2), 岡部志功1), 村上宗一郎1), 芦川芳史1), 弓削瑞葵1), 川口幸輝2), 島田康人1),2),3),4),5), 岡本隆二6), 伊藤正明6), 田中利男6) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 86-86, 2016. |
---|
![]() |
Elucidation of the molecular mechanism that angiotensin II makes casein kinase 2 α' β activate with B-26 juvenile cardiac muscle cells 柏原俊英, 中田勉, 山田充彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 87-87, 2016. |
---|
![]() |
The methylase inhibitor shows inhibitory effect for fibrosis in B-27 culture heart fibroblasts 佐藤光1), 村田謄行1), 刀坂泰史1),2),3), 砂川陽一1),2),3), 和田啓道2), 島津章2), 長谷川浩二2), 森本達也1),2),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 88-88, 2016. |
---|
![]() |
B-28 curcumin analog Y030 inhibited cardiac muscle cells enlargement response by inhibiting p300-HAT activity strongly 清水果奈1), 船本雅文1),2), 砂川陽一1),2),3), 刀坂泰史1),2),3), 柴田浩行4), 和田啓道2), 長谷川浩二2), 森本達也1),2),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 89-89, 2016. |
---|
![]() |
Effect on left ventricle shrinkage ability in the B-29 PRMT5 heart-specific overexpression mouse 若林弘樹1), 刀坂泰史1),2),3), 櫻井涼賀1), 砂川陽一1),2),3), 和田啓道2), 長谷川浩二2), 森本達也1),2),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 90-90, 2016. |
---|
![]() |
The signaling to go through the beta-2 adrenergic receptor of B-30 feeling fibroblasts brings about cardiac hypertrophy in a mouse 中山博之, 藤尾慈 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 91-91, 2016. |
---|
![]() |
Expression of B-31 G protein subunit Gαo sthenia is involved in the cardiac function failed in the dilated cardiomyopathy model mouse 稲住英明1), 桑原宏一郎1), 桑原佳宏1), 中川靖章1), 木下秀之1), 森内健史1), 錦見俊雄2), 呉林なごみ3), 柏原俊英4), 山田充彦4), 中尾一和5), 木村剛1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 26: 92-92, 2016. |
---|